Media › ADMA Biologics Statement on Tariffs
 
 

ADMA Biologics Statement on Tariffs

2025-04-22 09:45:03| Spiritual Career Counseling

Reiterates Strategic Advantage Through Fully U.S.-Based Manufacturing Operations, Commercialization and End-Market Sales, and Vertically Integrated U.S.-Based Supply Chain April 07, 2025 07:00 ET | Source: ADMA Biologics, Inc. RAMSEY, N.J. and BOCA RATON, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today provided a statement on the recent tariffs put in place and reiterated ADMAs strategic advantage through fully U.S.-based manufacturing operations, commercialization and end-market sales, and a vertically integrated U.S.-based supply chain. ADMA is a U.S.-based company with all manufacturing operations, end-market sales, and customer engagements conducted exclusively within the United States, said Adam Grossman, President and Chief Executive Officer of ADMA. The tariffs that have been implemented on...


Category: Employment

 

Latest from this category

All news
»
13.12Salah's farewell? If this was his final Liverpool chapter, he delivered a fitting end
13.12Blackhawks recall Lardis following Bedard injury
13.12Hawks' Young should return to practice next week
13.12Cowboys keep CB Diggs on IR for Vikings game
13.12Source: U-M launches athletic department query
13.12Live updates from NBA Cup semifinals between Magic-Knicks, Spurs-Thunder in Vegas
13.12Follow live: Army, Navy vie for Commander-In-Chief's Trophy as rivals meet in Baltimore
13.12Salah makes EPL history on Liverpool return
More »